logo
Plus   Neg
Share
Email

J Sainsbury Q1 Grocery Sales Up 10.5% On Strong Online Growth - Quick Facts

J Sainsbury plc (SBRY.L) reported first-quarter grocery sales growth of 10.5%, driven by very strong online growth.

The company's Q1 general merchandise sales were up 7.2%, including Argos sales growth of 10.7%. However, clothing sales declined 26.7% during the quarter, but have shown "encouraging signs of recovery during the latter half of the quarter, helped by Tu Online sales growth of 87 per cent and successful clearance activity."

Total retail sales for the quarter were 8.5% (excl. fuel) with like-for-like sales up 8.2% (excl. fuel).

Simon Roberts, Chief Executive Officer, said, "The coming weeks and months will continue to be challenging for our customers and our colleagues and we do not expect the current strong sales growth to continue. A number of the decisions we have made have materially increased costs but meant that we have done the right thing for our customers and set us up well for the future."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Volkswagen Group were gaining around 3 percent in German trading after the automotive giant Thursday reported market recovery in the third quarter with improved deliveries in the month of September. For the first nine months of fiscal 2020, the company, meanwhile reported sharply lower earnings with weak revenues and sales volume. Comcast Corp. on Thursday reported a 37 percent decline in profit for the third quarter from last year, hurt primarily by revenue decline at NBCUniversal. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. The company also declared a quarterly dividend. In the pre-market trade, CMCSA is trading at $42.83, up $0.85 or 2.02 percent. Regeneron announced positive results from its late stage COVID-19 outpatient trial, indicating that its antibody cocktail therapy significantly reduced virus levels and need for further medical attention. The trial results showed that investigational antibody cocktail, REGN-COV2, met the primary and key secondary endpoints.
Follow RTT